Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Mandeep Bajaj

Corresponding author: Mandeep Bajaj

[email]@hotmail.com

Name/email consistency: high

[Claim this account]

Affiliations

Corresponding author: Mandeep Bajaj. 2012
Diabetes Division, Department of Medicine, University of Texas Health Science Center, San Antonio, USA. 2002 - 2010

References

Nicotine and insulin resistance: when the smoke clears. Bajaj, M. Diabetes (2012) [Pubmed]
Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus. Bajaj, M., Baig, R., Suraamornkul, S., Hardies, L.J., Coletta, D.K., Cline, G.W., Monroy, A., Koul, S., Sriwijitkamol, A., Musi, N., Shulman, G.I., DeFronzo, R.A. J. Clin. Endocrinol. Metab. (2010) [Pubmed]
Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Bajaj, M., Suraamornkul, S., Hardies, L.J., Glass, L., Musi, N., DeFronzo, R.A. Diabetologia (2007) [Pubmed]
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Bajaj, M., Suraamornkul, S., Romanelli, A., Cline, G.W., Mandarino, L.J., Shulman, G.I., DeFronzo, R.A. Diabetes (2005) [Pubmed]
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. Bajaj, M., Suraamornkul, S., Piper, P., Hardies, L.J., Glass, L., Cersosimo, E., Pratipanawatr, T., Miyazaki, Y., DeFronzo, R.A. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Bajaj, M., Suraamornkul, S., Hardies, L.J., Pratipanawatr, T., DeFronzo, R.A. Int. J. Obes. Relat. Metab. Disord. (2004) [Pubmed]
Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic. Bajaj, M., Banerji, M.A. Curr. Diab. Rep. (2004) [Pubmed]
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. Bajaj, M., Suraamornkul, S., Kashyap, S., Cusi, K., Mandarino, L., DeFronzo, R.A. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Bajaj, M., Suraamornkul, S., Pratipanawatr, T., Hardies, L.J., Pratipanawatr, W., Glass, L., Cersosimo, E., Miyazaki, Y., DeFronzo, R.A. Diabetes (2003) [Pubmed]
Metabolic and molecular basis of insulin resistance. Bajaj, M., Defronzo, R.A. J. Nucl. Cardiol (2003) [Pubmed]
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans. Bajaj, M., Berria, R., Pratipanawatr, T., Kashyap, S., Pratipanawatr, W., Belfort, R., Cusi, K., Mandarino, L., DeFronzo, R.A. Am. J. Physiol. Endocrinol. Metab. (2002) [Pubmed]
Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes. Bajaj, M., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Kashyap, S., Cusi, K., Mandarino, L., DeFronzo, R.A. Diabetes (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.